Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Merck and Co., Inc. reported that it has received a letter from the U.S. Attorney's Office for the District of Massachusetts advising the company that it is a target of a previously-disclosed federal grand jury investigation. The investigation relates to activities in connection with VIOXX, a medicine that Merck voluntarily withdrew from the market in 2004. The company has previously disclosed the government's investigation, which has been ongoing since 2004, in various filings with the U. S. Securities and Exchange Commission.

Today in Marketing/Media/ROI...keeping you current

Hospira Buys Infection Control Vendor
HealthDataManagement, 12/11/09

Mediware Makes Two Buys
HealthDataManagement, 12/10/09

Visanne cleared for market launch in Europe as new treatment option for endometriosis
BayNews International, 12/08/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address